NervGen Pharma Corp.: NervGen Pharma Grants Stock Options

Vancouver, British Columbia--(Newsfile Corp. - July 15, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing

Related Keywords

United Kingdom ,Vancouver ,British Columbia ,Canada ,British ,Nancy Thompson ,Huitt Tracey ,Linkedin ,Corporate Communications ,Facebook ,British Columbia Newsfile Corp ,Regulation Services Provider ,Nervgen Pharma Corp ,Venture Exchange ,Gen Pharma ,Vorticom Public ,Nervgen ,Dharma ,Orp ,Migrants ,Stock ,Options ,